No profile data available.
PharmaCyte Biotech, Inc. (PMCB) is a healthcare company in the additional cancer treatment drugs industry, based in Las Vegas, United States, with about 2 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of $23.36 million. In Q3 2026 (the quarter ended January 31, 2026) revenue was $0. Its market capitalization was $4.34 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended April 30, 2025; market data as of October 9, 2026.
, a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States.
PharmaCyte Biotech reported $0 in revenue for fiscal year 2025. In Q3 2026 revenue was $0.
$4.34 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Imunon, Inc. (IMNN), Liminatus Pharma, Inc. (LIMN), NuCana plc (NCNA), Processa Pharmaceuticals, Inc. (PCSA).